NewsRoom Articles - Page 190 of 214

TuesdayNov 03, 2020 10:00 am

Researchers Can Predict Whether Rheumatoid Arthritis Patients Will Respond to Treatment

A new study conducted by researchers at the Queen Mary University of London has produced innovative biomarkers that can be used to predict patient responsiveness to DMARDs (disease-modifying anti-rheumatic drugs). Rheumatoid arthritis is an inflammatory disorder that can affect not only one’s joints but also blood vessels, heart, lungs, eyes and skin. The disease causes painful swelling that results in joint deformity and bone erosion. Patients with rheumatoid arthritis are usually treated using disease-modifying anti-rheumatic drugs. This is despite the fact that almost 50% of rheumatoid arthritis patients are unresponsive to DMARD treatment. Up until now, no method was available…

MondayNov 02, 2020 12:00 pm

Korean Researchers Develop Artificial Coating to Avert Bone Inflammation

Due to population aging, bone disease is becoming increasingly widespread. This trend has led to an increase in the use of orthopedic and dental implants to treat the condition. We can trace the history of implants all the way back to 1 AD, when wrought iron was fashioned into dental implants in ancient Rome. Despite the long history, various challenges are still linked to implant procedures, including inflammation or a loose implant stemming from slow fusing to the bone tissue. To help mitigate these problems, an attempt has been made to coat implant materials with artificial bone, which has the…

MondayNov 02, 2020 11:33 am

VistaGen Therapeutics Inc. (NASDAQ: VTGN) Preclinical Study Data Show Drug Combo’s Innovative Potential in Fight Against Major Depressive Disorder

Study results have exciting therapeutic potential across wide range of CNS indications. VTGN focused on developing new generation of medications to treat anxiety, depression and more. Company committed to finding treatment to help estimated 264 million people around the world who suffer from depression. Noting that 17.3 million adults in the United States have had at least one major depressive episode and some 264 million people around the world suffer from depression, VistaGen Therapeutics (NASDAQ: VTGN) is committed to finding effective treatments for depression that reach beyond the current standard of care, which includes oral antidepressants and oral atypical antipsychotics.…

MondayNov 02, 2020 11:04 am

CNS Pharmaceuticals (NASDAQ: CNSP) Announces Completion of Drug Manufacturing for Brain Cancer Trial

Houston-based CNS Pharmaceuticals is preparing to launch Phase 2 clinical testing of a novel brain cancer-fighting drug candidate called Berubicin early next year The biopharmaceutical company recently announced that a U.S.-based company contracted to make Berubicin has completed its production process and an Italian company working on a dual track in Europe is expected to finish by the end of the year Berubicin has shown promise in combatting Glioblastoma multiforme, an aggressive form of brain cancer commonly regarded as incurable. One participant in Berubicin’s Phase 1 trial remains cancer-free 14 years after the trial CNS Pharmaceuticals, with its sublicensee partner…

MondayNov 02, 2020 10:00 am

Findings Suggest Link Between Deficiencies in Gut Microbes, Autism Spectrum Disorder

A group of researchers associated with various institutions in China has discovered a gut microbe deficiency in children who develop ASD (autism spectrum disorder). This is a developmental disability characterized by stereotyped and repetitive behavior and impaired social communication. In the research, which was published in the “Science Advances” journal, the team of researchers describes their study of gut microbes in autism spectrum disorder children and discusses their findings. Previous research had suggested that issues with the gut microbiome may be the cause of the development of ASD in the affected children. However, what those issues might be still remains…

FridayOct 30, 2020 12:00 pm

Researcher Develops App to Help Kidney, Heart Disease Patients Manage Diets

For many living with heart and kidney diseases, taking care of their health includes managing their diets to suit medical recommendations that restrict the consumption of some nutrients. While this might be easy for some, a majority find it hard to follow these recommendations without tracking their nutrition through the day. To help with this, assistant professor and nephrologist Dr. Ibrahim Elali has created DecideDiet. This free smartphone app allows patients to manually record or scan the bar code of the food they are about to eat. The app automatically evaluates the potassium, or sodium content, of the food item…

FridayOct 30, 2020 10:00 am

COVID-19 Deals Chronic Disease Patients a Double Blow

A new study conducted by the University of New South Wales has discovered that right now is the most dangerous time for individuals with NCDs (noncommunicable diseases) such as cardiovascular conditions, respiratory problems, cancer and diabetes — primarily because of the COVID-19 pandemic. The study found that individuals with NCDs were more likely to contract the virus and succumb to it, especially since their exposure to NCD risk factors such as unhealthy diets, social isolation and substance abuse has increased amid the pandemic. The researchers also discovered that the coronavirus disrupted essential public health services, which many individuals who live…

ThursdayOct 29, 2020 12:00 pm

Approximately One-Third of US Young Adults Are Unaware of Common Signs of a Stroke

According to new research that was published in “Stroke,”, approximately 30% of adults below age 45 in the United States don’t know the five most common stroke symptoms. Strokes are the main cause of disability in the country as well as the fifth leading cause of death. Between 10% to 15% of the 795,000 individuals who suffer a stroke are young people, aged between 18 and 45, so recognizing the signs is vital. Other recent studies suggest that while stroke incidence is decreasing among the general population, its incidence and hospitalizations have grown by more than 40% in young people…

ThursdayOct 29, 2020 10:00 am

Biomedical Engineer Invents Technique That May Help Improve Eyesight

A professor of biomedical engineering at the University of Miami College of Engineering, Noel Ziebarth, and her groundbreaking research may help in the development of treatments designed to help the blind see again. The professor is also head of the Biomedical Atomic Force Microscopy Lab where she uses scanning electron, atomic force and confocal microscopes to analyze the retina, cornea and lens of the human eye in its diseased and normal states. Ziebarth is mainly interested in treatments that may be used to treat cataracts. Cataracts are the clouding of the lens of the eye, which is normally clear, and…

WednesdayOct 28, 2020 12:00 pm

Men More Likely to View Face Masks as Infringement on Freedom

According to new research that was published in the “Personality and Individual Differences” journal, both women and men are equally likely to wear face masks during the coronavirus pandemic. However, the study shows that women and men tend to have contrasting reasons for not wearing face masks. Matt C. Howard, an assistant professor at the University of South Alabama, is a researcher involved in this study. His interest in the matter arose after reading a few popular news reports that claimed that men were less likely to wear face masks. This is despite recent research that indicated that both women…